SWITCHING FROM DOUBLE-BLIND ENTACAPONE OR PLACEBO TO OPEN-LABEL OPICAPONE: NMSS RESULTS (1-YEAR EXTENSION BIPARK-I STUDY)

被引:0
|
作者
Fabregues, O. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Santos, A. [5 ]
Rocha, J. [6 ]
Soares-Da-Silva, P. [5 ]
机构
[1] Univ Hosp Vall dHebron, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[6] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源
关键词
D O I
10.1136/jnnp-2019-ABN-2.133
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
141
引用
收藏
页码:E49 / E49
页数:1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
    Deodhar, A.
    Van der Heijde, D.
    Sieper, J.
    Van den Bosch, F.
    Maksymowych, W. P.
    Kim, T. H.
    Kishimoto, M.
    Ostor, A.
    Combe, B.
    Sui, Y.
    Wang, X.
    Chu, A.
    Song, I. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 85 - 86
  • [22] Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis: 1-Year Results From a Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension
    Maksymowych, Walter
    van der Heijde, Desiree
    Sieper, Joachim
    van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina
    Song, In-Ho
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1122 - 1122
  • [23] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
    Deodhar, Atul
    van der Heijde, Desiree
    Sieper, Joachim
    Van den Bosch, Filip
    Maksymowych, Walter
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina D.
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Opicapone and non-motor symptoms in Parkinson's disease: Results from a double-blind, randomized, placebo-controlled study and open-label extension
    Oliveira, C.
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S173 - S173
  • [25] Safety of opicapone in fluctuating Parkinson's disease patients: Results of the 1-year extension of study BIPARK I
    Santos, A.
    Ferreira, J.
    Lees, A.
    Stocchi, F.
    Rascol, O.
    Lopes, N.
    Gama, H.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2016, 31 : S641 - S641
  • [26] Results from the BIPARK-I double-blind experience on the efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations.
    Kulisevsky, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 650 - 650
  • [27] Topiramate in migraine prophylaxis: An open-label extension of a double-blind, placebo-controlled study
    Hart, DE
    Calder, CS
    Storey, JR
    Riback, P
    Potter, DL
    Wymer, JP
    Beesley, BA
    NEUROLOGY, 2002, 58 (07) : A496 - A497
  • [28] Opicapone's safety in Parkinson's disease patients with motor fluctuations: results of the 1-year extension of study BIPARK I
    Santos, A.
    Ferreira, J.
    Lees, A.
    Stocchi, F.
    Rascol, O.
    Lopes, N.
    Gama, H.
    Rocha, J. F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 662 - 662
  • [29] Evaluation of non-motor symptoms in opicapone treated Parkinson's disease patients: results from a double-blind, randomized, placebo-controlled study and open-label extension
    Oliveira, C.
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 191 - 191
  • [30] Growth hormone deficiency and replacement therapy in Japan: Results of placebo-controlled double-blind study and open-label extension study
    Shimatsu, A.
    Tai, S.
    Kato, Y.
    Kohno, H.
    Tanaka, T.
    Teramoto, A.
    Chihara, K.
    DECADE OF HYPOCCS: THE CHANGING FACE OF PITUITARY DISEASE, 2008, 10 : 171 - +